Condition

Acid Cholesteryl Ester Hydrolase Deficiency, Type 2 (2)

Cholesterol Ester Storage Disease (2)

Wolman Disease (2)

Acid Lipase Deficiency (1)

LAL-Deficiency (1)

LIPA Deficiency (1)

Lysosomal Acid Lipase Deficiency (1)

Overall Status

Completed (1)

Recruiting (1)

Phase

Sponsor

Alexion Pharmaceuticals (1)

Children's Hospital Medical Center, Cincinnati (1)

Collaborator

National Center for Advancing Translational Science (NCATS) (1)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)

National Institute of Neurological Disorders and Stroke (NINDS) (1)

Rare Diseases Clinical Research Network (1)

Intervention

there are no interventions in this study. (1)

Study Documents

Intervention Type

other (1)

Funder Type

Industry (1)

Other (1)

Study Type

Observational (1)

Observational [Patient Registry] (1)

acid cholesteryl ester hydrolase deficiency, type 2

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Lysosomal Acid Lipase Deficiency, Cholesterol Ester Storage Disease, Wolman Disease Trial in Worldwide

Recruiting

Lysosomal Acid Lipase Deficiency
+6 more

Stanford, California
+27 more

Jan 11, 2021

Review and Longitudinal Follow-Up

Completed

Wolman Disease
+2 more

There are no interventions in this study.

Cincinnati, Ohio

Cincinnati Children's Hospital Medical Center

Jul 27, 2015